Table 3.
Association of rs2702185 with survival across different intervals of disease progression.
| Surgery to Biochemical Recurrence | Biochemical Recurrence to Death of Disease | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | P | HR LCL | HR UCL | HR | P | HR LCL | HR UCL | ||
| Age at Surgery | 0.949 | 1.96E-13 | 0.935 | 0.962 | 1.008 | 6.39E-01 | 0.974 | 1.043 | |
| PSA | 1.008 | 1.05E-03 | 1.003 | 1.013 | 0.991 | 1.56E-01 | 0.979 | 1.003 | |
| Stage 3–4 (Ref: Stage 1–2) | 1.424 | 1.25E-02 | 1.079 | 1.879 | 1.196 | 5.06E-01 | 0.706 | 2.028 | |
| Gleason Score 7 (Ref: Gleason Score <7) | 3.242 | 8.02E-14 | 2.381 | 4.414 | 1.571 | 2.76E-01 | 0.697 | 3.541 | |
| Gleason Score 8–10 (Ref: Gleason Score <7) | 4.012 | 4.24E-15 | 2.836 | 5.676 | 3.891 | 1.05E-03 | 1.727 | 8.769 | |
| rs2702185 | 1.112 | 4.91E-01 | 0.822 | 1.503 | 2.537 | 1.36E-03 | 1.435 | 4.485 | |